申请人:Syntrix Biosystems, Inc.
公开号:US20140171436A1
公开(公告)日:2014-06-19
The present invention is a method of treating antifolate neurotoxicity in a mammal suffering from or at risk of developing antifolate neurotoxicity, which comprises administering to the mammal a therapeutically effective amount of an NMDA antagonist, or a pharmaceutically acceptable salt thereof.